Is Hydroxychloroquine Safe During Pregnancy? Observations from Penn Medicine

By Lena M. Davidson, Silvia P. Canelón, Mary Regina Boland in Research

May 8, 2020

Abstract

A novel strain of coronavirus appeared in December 2019. Over the next few months, this novel coronavirus spread throughout the world, being declared a pandemic by the World Health Organization on March 11, 2020. As of this writing (March 28, 2020) over one hundred thousand individuals in the United States of America were confirmed cases. One way of treating the associated disease, COVID-19, is to reuse existing FDA-approved medications. One medication that has shown promise is hydroxychloroquine (HCQ). However, the utility and safety of HCQ among pregnant COVID-19 patients remains a concern.

Posted on:
May 8, 2020
Length:
1 minute read, 93 words
Categories:
Research
Tags:
EHR covid-19 medications pregnancy English
See Also:
A Bayesian Hierarchical Modeling Framework for Geospatial Analysis of Adverse Pregnancy Outcomes
Individual-Level and Neighborhood-Level Risk Factors for Severe Maternal Morbidity
The Impact of Sickle Cell Status on Adverse Delivery Outcomes Using Electronic Health Record Data